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The possible role of chromosome X variability in hypertensive
familiarity
M Ciccarelli1, R Finelli1, N Rivera2, G Santulli3, R Izzo4, N De Luca4, F Rozza4, M Ceccarelli5,6, S Pagnotta5, F Uliano5, R Tremigliozzi5,
G Condorelli7, V Trimarco8 and G Iaccarino1
Familiarity participates in the pathogenesis of hypertension, although only recently, whole genome studies have proposed regions
of the human genome possibly involved in the transmission of the hypertensive phenotype. Although studies have mainly focused
on autosome, hitherto the influence of sex on familial transmission of hypertension has not been considered. We analysed the
database of the Campania Salute Network of Hypertension center of the Federico II University Hospital of Naples (Italy), using
dichotomous variables for paternal and maternal familiarity and gender (male and female) of 12 504 hypertensive patients
(6868 males and 5636 females) and 6352 controls (3484 males and 2868 females), totaling 18 856 subjects. In the hypertensive
group, familiarity was present in 75% of cases with odds of 3.77 and in only 26% of the normotensives with odds of 0.94. The odds
ratio (OR) indicated that familiarity increases the risk of developing hypertension by 2.91 (95% confidence interval (CI) = 2.67–3.17,
Po0.001) times. Additionally, maternal familiarity was 37% (OR= 3.01, 95% CI = 2.66–3.41, Po0.001), paternal familiarity was 21%
(OR= 2.31, 95% CI = 2.01–2.68, Po0.001) and the double familiarity was 17% (OR= 3.45, 95% CI = 2.87–4.01, Po0.001), thus
suggesting a plausible association between maternal familiarity and development of hypertension; this finding was observed both
in male and in female patients, although the phenomenon was larger in males. Given the dominance of maternal transmission in
males, by genome-wide analysis of the X chromosome, we found two regions that were differently distributed in male
hypertensives with maternal hypertension. Our data highlight the importance of genetic variants in the X chromosome to the
maternal transmission of the hypertensive phenotype.
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INTRODUCTION
Blood pressure, like height and weight, is a continuous biological
variable. The relationship between the level of blood pressure and
cardiovascular risk has led to a definition of hypertension for those
of arterial blood pressure associated with doubling of long-term
cardiovascular risk.1
About one-fourth of the world’s population (70 million in the
United States and 1 billion worldwide) is affected by arterial
hypertension, which is the main cardiovascular risk factor and the
leading cause for an outpatient visit to physician.2
Currently, about 54% of strokes and 47% of ischaemic heart
disease worldwide are attributable to high blood pressure. In
addition, because of increasing rates in obesity and aging,
hypertension is projected to affect 1.5 billion people, that is,
about one-third of the world population, by the year 2025.2
Essential hypertension is a disease with a significant phenotypic
heterogeneity and among hypertensives several differences can
be considered. Indeed, hypertension phenotypes can involve
different mechanisms, such as the increase in aortic stiffness, the
presence of metabolic syndrome and endothelial dysfunction,
which influence can greatly differ within populations.3 For
example, aortic stiffness accounts for mostly of the isolated
systolic hypertension observed in elderly patients.4,5 On the
contrary in young adult, hypertension is often associated with
metabolic abnormalities or metabolic syndrome that includes
different clinical conditions such as the association of visceral
obesity and metabolic disorders.6 Nonetheless, clinical manifesta-
tions of hypertension can be determined by the variability of
genetic variants along with epigenetic components in the human
genome.
In essential hypertension, familiarity is present in 90% of cases,
but a Mendelian transmission of hypertension is rarely observed.
For complex and polygenic diseases such as hypertension, two
main strategies are available to map and identify the genes
involved: (1) Linkage studies (Genome Wide Linkage), which are
based on a known genetic model or when the model is unknown,
studying pairs of affected relatives; and (2) Association studies
(Genome Wide Association), where disease genes can be mapped
using allelic association studies under a hypothesis-free
approach.7 The influence of specific genes on blood pressure
level has been demonstrated by family studies, showing increased
prevalence among siblings and between parents and children.
Moreover, blood pressure level can be accounted for by genetic
factors, spanning from 25% in pedigree studies to 65% in twin
studies.8,9
Two measures are typically used to evaluate the genetic
component of a phenotype: (1) heritability (h2), measuring
susceptibility to develop the disease due to genetic factors and
(2) sibling recurrent risk (λs), which is the degree of risk of illness
for a sibling of an affected individual compared with the general
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population. However, both heritability and sibling recurrent risk
have shown a high variability on the related impact of the genetic
trait to the observed phenotype. In hypertension, heritability
changes from 15 to 40% and 15 to 30% for systolic and diastolic
blood pressure, respectively, while the sibling recurrent risk ranges
from 1.2 to 1.5, indicating a phenotype with a modest genetic
effect.10,11
Therefore, the overall search for genetic determinants of
hypertension has incurred in several difficulties mainly related to
the extreme variability of hypertensive phenotypes.10,11
A different approach may involve evaluation of intermediate
phenotypes of hypertension by using techniques of genetic
association. Specifically, patients clustering could be helpful in
reducing the interference produced by the background and
leading to a more homogeneous sample.
In the present study, we aimed to a selected population from
the ‘Campania Salute Network—CSN’ database following a
clustering approach taking into account phenotype, gender and
familiarity, and found that prevalence of maternal transmission is a




For this study, we selected a total of 18 856 subjects consisting of 12 520
hypertensive patients (6868 males and 5636 females) and 6352 patients
(3484 males and 2868 females) with cardiovascular disease excluding
hypertension, which were used as controls. All parameters, including
anamnesis, physical examination, blood and urinary biochemistry, EKG,
cardiac and vascular ultrasound and ambulatory blood pressure
monitoring were collected during ambulatory visits and stored in the
server of the CSN outpatient clinic, an open registry collecting information
from general practitioners and community hospitals in Campania Region,
Italy. The Federico II University Institutional Ethic Committee approved
both the database and the informed consent form of CSN. Detailed
characteristics of CSN population have been previously reported.12–14
DNA extraction
Genomic DNA was extracted from whole blood sample of 1200 patients
using a commercially available extraction kit (QuiagenMidi, Chicago, IL,
USA).15
Informed consensus to the study was obtained from patients, which was
previously approved by the Institutional Ethics Committee. The study was
conducted according to the ethical principles that have their origins in the
Declaration of Helsinki.
Genotyping
Genotyping was performed with 320 K Infinium II Assay-HumanHap 317 K
duo BeadChip system SNP-array, according to the manufacturer’s protocol
(Illumina, San Diego, CA, USA). Quality of genotypes was evaluated by the
GenCall score, which reflects the proximity within a cluster plot of
the intensities of that genotype to the centroid of the nearest cluster.
The score ranges from 0 to 1.
Quality control
Single-nucleotide polymorphisms (SNPs) with call rate o95%, minor allele
frequency o5% and Hardy–Weinberg Equilibrium Po1×10−3 were
excluded from the analysis. Quality control filters output 218 000 SNPs from
the 317 K array. Samples that had call rate o95% were also excluded.
Moreover, exclusion of samples due to population stratification was performed
using principal component analysis, which was conducted on a reduced set of
autosomal markers showing r2o0.2 and using the default outliers removal
threshold (sigma=6) as implemented in Eigenstrat software.16
Imputation
Quality-controlled data set was imputed using build 36, release 22 HapMap
CEU populations as the reference. Approximately 2.5 million SNPs were
imputed using maximum likelihood method implemented in the MACH 1.0
software.17,18
Linkage disequilibrium analysis
Haploview v4.2 software was used for linkage disequilibrium analysis.19
We estimated Haplotype blocks using the confidence intervals rule
while Haplotype phases were inferred using the default expectation
maximization algorithm.
Power calculation
QUANTO software was performed to evaluate Power Calculation.
Specifically, we used the following settings: allele frequency ranging from
0.05 to 0.95, and significance threshold (P) for the screening analysis set to
Po1 × 10− 4 evaluating allelic, dominant and recessive genetic models.20
This last was identified by estimating the false-positive fraction on
simulated data sets. Data simulation was carried out by generating 100
independent data sets composed by 317 K SNPs, with minor allele
frequency distribution ranging from 5 to 50%, and 963 controls of which
410 were labelled as ‘case’ and 553 as ‘control’ in a random manner. We
tested for association between each marker and case/control status
assuming allelic, dominant and recessive genetic models and then selected
the most significant model as the most informative for the SNP of interest.
For each significant threshold (ranging 0.05oPo1x10− 7), the mean
fraction of false-positive associations (a false-positive association was
defined as an SNP with P lower than the selected significance threshold, P)
was estimated over 100 simulated data sets for each P.
Statistical analysis for association
Distribution analysis was performed using the chi-squared test. When
comparing family history of hypertension frequencies, those observed in
male hypertensive patients were referred to those observed in female
hypertensives.
Association between the set of SNPs passing the quality control criteria
and the phenotype selected was tested by Pearson chi-squared allelic
association test with one degree of freedom (df) (a (minor allele) vs A (major
allele), assuming a dominant (aa/aA vs AA, 1 df) and a recessive (aa vs aA/
AA, 1 df) genetic effect. Logistic regression under additive, dominant and
recessive genetic models was applied to estimate the odd ratio (OR) and
95% confidence interval (CI) for each of the different genetic models to
ascertain potentially confounding gender-specific effects. Adjustment for
potential confounding effects was considered by genomic control




Our study was carried out in a total of 18 856 subjects, that is,
12 504 patients with clinical history of hypertension (6868 males
and 5636 females), and 6352 cardiovascular patients without
Table 1. Anthropometric data of 12 504 patients with clinical history of hypertension (6868 male and 5636 female) compared with the data of 6352
patients without diagnosis of hypertension (designated as controls)
Age (years) Gender F/M(%) Weight (kg) Height (cm) BMI (kg m−2) SBP (mm Hg) DBP (mm Hg)
Hypertensive 52.44± 0.1 44%/56% 78.2± 0.2 167.41± 0.1 27.85± 0.05 142.25± 0.2 88.44± 0.1
No hypertensive 45± 0.54 48%/52% 74.91± 0.7 169.18± 0.5 26.3± 0.6 128.44± 2.1 81.06± 1.8
Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; SBP, systolic blood pressure.
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diagnosis of hypertension (3484 males and 2868 females) that are
enrolled in the database, and that had access to the outpatient
clinic for possible diagnosis hypertension that was eventually
excluded, or for ischaemic, cardiac valve or arrhythmic disease
that was not associated with hypertensive status. Population was
homogenous for prevalence of cardiovascular disease (coronary
artery disease, heart failure and implantation of electrical
stimulation devices) (Table 1).
Phenotype and familiarity
Familiarity was present in 75% of the hypertension cases and only
in 26% of the normotensives (Figure 1). The likelihood (defined by
the odds) of familiarity was significantly higher in the hypertensive
group with respect to the normotensive patients (3.77 vs 0.94).
Likewise, the relative risk expressed as OR was 2.91 (95% CI = 2.66–
3.17, Po0.001) times more frequent in the hypertensive patients
than in normotensives (Figure 2). These results suggest that
offspring of parents with hypertension have three times higher
risk to develop hypertension in adult life than children of
normotensive parents.
Familiarity and gender in the hypertensive group
We divided hypertensive patients with family history of hyperten-
sion into subcategories according to the presence of maternal,
paternal or double familiarity. We found that almost 50% of
hypertensive patients had maternal familiarity, and this number
increased to almost 75% when considering those hypertensives
with double familiarity, as illustrated in Figure 3. Analysis of
familiarity in relation to gender revealed that in the female
hypertensive group, 69% had maternal familiarity, alone or in
double familiarity (Figure 3), whereas in the male hypertensive
group this percentage raised to 76%, as 51% had maternal
familiarity and 25% had double familiarity (Figure 3). The
difference in the observed cases of maternal hypertension
observed in hypertensive males compared with those observed
in hypertensive females was very statistically significant, when
compared by the chi-square test (Po0.0001). Therefore, the
maternal transmission of hypertension is more often observed in
male than in female hypertensives in our population.
X-chromosome SNPs and hypertensive familiarity
Prevalence of maternal familiarity of hypertension suggests that
the X chromosome is involved in determining the hypertensive
phenotype. To explore this hypothesis, we used genome-wide
genotype data of 615 hypertensive patients currently available in
our database. Our analysis identified two genetic regions in the X
chromosome that were significantly associated with the familiarity
phenotype (Figure 4). The polymorphisms included in these
regions, with levels of association by a P-value of o10−3, are
illustrated in Tables 2 and 3.
Weight of X-chromosome SNPs in clustered hypertensive patients
The specific weight of the X chromosome in the transmission of the
hypertensive phenotype was evaluated by dividing the hyperten-
sive population by gender and maternal familiarity (Table 4). This
table shows all SNPs located in the X chromosome with Po0.001.
We observed a difference in allele frequency distribution of SNPs in
male patients compared with female patients. Moreover, within
male group, a comparison of SNPs allele frequency between
‘hypertensive mother male’ and ‘not hypertensive mother male’
showed opposite findings. For example, the frequency of allele B in
the first group was higher than the one detected in all hypertensive
patients and lower in the second group, or vice versa. However,
these observations were not found in the female group (Table 4).
Therefore, these data show that in males, a maternal family history
of hypertension is associated with a higher SNPs variability on the X
chromosome with respect to either female group or the general
hypertensive population.
DISCUSSION
This work can be summarized in three key points: (1) the
prevalence of maternal familiarity in the hypertensive population,
Figure 1. Higher frequency of family history of hypertension among
hypertensive patients. Patients with hypertension presented more
often family history of hypertension (left column) than non-
hypertensive patients used as a control (right column). Statistic
significance was assessed by chi-square test, Po0.001.
Figure 2. Likelihood of a family history of hypertension expressed as
odds is different between hypertensive patients (in green) and
non-hypertensive patients used as controls (in red). The relative
risk expressed as the OR indicates that familiarity increases the
risk of developing hypertension by 2.91 (95% CI= 2.67–3.17,
Po0.001) times.
Figure 3. Presence of maternal, paternal or double familiarity of
hypertension among the hypertensive patients with family history
of hypertension, as whole or divided by gender. The number of
observed cases of maternal hypertension history among hyperten-
sive males was much larger than that expected using hypertensive
female as a reference (5220 vs 4769, Po0.0001, chi-square test).
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(2) the association between familiarity and maternal X
chromosome and (3) the observation that maternal familiarity
has a greater weight in hypertensive men.
The link between familiarity and hypertension is well
demonstrated in the literature.8,9 Moreover, in selected
populations the role of genetic factors appears to be likely
predominant with respect to the environment.23,24 However,
the specific weight of familiarity is still underestimated for
confounding factors in the general population. Our data support
the hypothesis that the role of genetic trait on hypertension
phenotypes can be unveiled by filtering and clustering a selected
population, and allows to identify specific genetic factors for
hypertension.
Our study takes place by the observed lack of data on maternal
familiarity, probably due also to the low diffusion of detailed
database. We overcame this limitation by using a digital medical
record, started in 1997 with a high level of Information
Communication Technology. This technology has allowed an easy
clustering of patients present in the database into subcategories.
The association between maternal familiarity and hypertension
has been previously occasionally reported, with opposite
outcomes.25 The genetics analysis was previously performed on
the variation of the mitochondrial DNA, which is maternally
transmissed.26 Our study identifies for the first time the possible
role of the X chromosome in familiar transmission of hypertension.
The X chromosome appears to be neglected in genome-wide
association studies despite several works in the literature showing
the role of sex chromosomes in increased susceptibility to
hypertensive mice.25,27
Therefore, using a Genome Wide Analysis method in combina-
tion with a clustering approach for investigating the role of the X
chromosome, we identified a number of SNPs that are
associated with defined trait ‘maternal familiarity for
hypertension’.
The X-chromosome SNPs observed in our study are also
associated with other diseases, such as SNP rs10521976
located in the DMD gene, which is responsible for Duchenne
Muscular Dystrophy (DMD) and Becker Muscular Dystrophy.
DMD is a fatal X-linked recessive disease that affects 1 in 3500
males and at an advanced stage the disease progresses to left
ventricular dysfunction and development of pulmonary
hypertension.28 This observation supports the role of the
X chromosome in the determination of blood pressure and
hypertensive phenotype with mechanisms that are yet to be
elucidated. The male patients, genetically equipped with only
one X chromosome, appear to be a category in which the weight
of the X-chromosome variability is stronger.
Some limitations of this study need to be considered: (1) the
small number of patients subjected to genetic evaluations for
which the values of P-values are not genome-wide
significant (defined as Po1x10-8). However, the clustering of
data from a well-documented database allowed us
to be confident that the results presented herein
are plausible; (2) we did not propose a specific pathogenic
hypothesis since we have considered only two regions
in the X chromosome and the relative SNPs without focusing
on specific gene(s). However, this could also be considered as a
more realistic approach given the multifactorial nature of
hypertension.
In the future, investigation of the role of sex in transmittance
of the hypertensive phenotype should take into account the
X chromosome and the mitochondrial DNA variability in an
integrated manner.
Finally, trying to translate our findings onto the clinical scenario,
we found that the presence of maternal familiarity can predict
development of hypertension in males.
Figure 4. Summary of the levels of significance for all SNPs on the X
chromosome as two peaks are observed. The green line links SNPs
that have − log10 (P-value)42.5 (i.e., Po0.001), while the red line
links SNPs with − log10 (P-value)42 (i.e, Po3.1 × 10−3). Two regions
of chromosome X associate with a higher level of significance to
maternal history of hypertension: one is comprised between
10000000 and 52058362 bp; the other one ranges from 123825787
to 168825787 bp.
Table 2. Summary of SNPs that are located in the region of the X
chromosome that extends up to the position 52058362
SNPs Position − log10 (P-value) P-value Gene
rs3915296 7788738 2.22879 0.005905 No
rs845122 7790764 2.055776 0.008795 No
rs2304605 12537957 2.011001 0.00975 FRMPD4
rs5986678 26751837 2.063741 0.00864 No
rs10521976 31606813 2.255675 0.00555 DMD
rs1317098 32058362 3.027029 0.00094 DMD
rs2182289 33035448 2.722287 0.0019 DMD
rs4366220 33277344 2.203242 0.00626 No
rs5917336 39704495 2.167296 0.0068 No
rs2284116 40936724 2.039422 0.00913 USP9X
rs5952767 45222263 2.504622 0.00313 No
rs2148106 45783625 2.470942 0.00338 No
Abbreviations: DMD, Duchenne Muscular Dystrophy; SNP, single-
nucleotide polymorphism.
Table 3. SNPs located within the region of the X chromosome that
extends from 123825787 to 168825787 base pairs
SNPs Position − log10 (P-value) P-value Gene
rs582694 125000000 2.471 0.00338 No
rs209637 125000000 2.885 0.00130 No
rs5932441 127000000 2.176 0.00666 No
rs243451 132000000 2.345 0.00452 HS6ST2
rs912002 135000000 2.250 0.00562 GPR112
rs6635268 135000000 2.181 0.006586 GPR112
rs6634180 140000000 2.051 0.00889 No
rs6528726 140000000 2.419 0.00381 No
rs5908269 141000000 2.086 0.00820 No
rs1989382 142000000 2.029 0.00934 No
rs5920360 144000000 4.066 0.00009 No
rs5966378 144000000 2.291 0.00512 No
rs7881233 144000000 3.507 0.00031 No
rs5920193 145000000 2.056 0.00880 No
rs7883888 147000000 2.025 0.00945 No
rs524400 149000000 2.169 0.00678 MAMLD1
rs743642 152000000 2.803 0.00158 BGN
Abbreviation: SNP, single-nucleotide polymorphism.
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What is known about this topic?
● Familiarity has a big role in the setup of hypertension and
hypertension-related complications.
● Contradictive data are available for the prevalence of maternal
transmission of hypertension.
● Some mechanistic data suggest that mitochondrial DNA variability
might participate to maternal transmission of hypertension to
offspring.
What this study adds?
● Confirms and quantifies the impact of maternal transmission of
hypertension.
● Identifies in males a population more prone to maternal
transmission of hypertension.
● Proposes that X-chromosome variability participates in maternal
transmission of hypertension to male offspring.
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